Correlation Between Day One and Avidity Biosciences
Can any of the company-specific risk be diversified away by investing in both Day One and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Avidity Biosciences, you can compare the effects of market volatilities on Day One and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Avidity Biosciences.
Diversification Opportunities for Day One and Avidity Biosciences
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Day and Avidity is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of Day One i.e., Day One and Avidity Biosciences go up and down completely randomly.
Pair Corralation between Day One and Avidity Biosciences
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.55 times more return on investment than Avidity Biosciences. However, Day One Biopharmaceuticals is 1.81 times less risky than Avidity Biosciences. It trades about -0.12 of its potential returns per unit of risk. Avidity Biosciences is currently generating about -0.11 per unit of risk. If you would invest 1,481 in Day One Biopharmaceuticals on September 5, 2024 and sell it today you would lose (122.00) from holding Day One Biopharmaceuticals or give up 8.24% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Day One Biopharmaceuticals vs. Avidity Biosciences
Performance |
Timeline |
Day One Biopharmaceu |
Avidity Biosciences |
Day One and Avidity Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Day One and Avidity Biosciences
The main advantage of trading using opposite Day One and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Avidity Biosciences vs. Candel Therapeutics | Avidity Biosciences vs. Cingulate Warrants | Avidity Biosciences vs. Unicycive Therapeutics | Avidity Biosciences vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |